Trial Profile
A Phase 1, Healthy Volunteer Qualification Of Ligand [11C] PF-04767135 And Randomized Determination Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs PF 4455242 (Primary)
- Indications Bipolar depression
- Focus Pharmacokinetics
- Sponsors Pfizer
- 27 Nov 2014 New trial record